Sichuan Biokin Pharmaceutical Co (SHSE:688506) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688506 Sichuan Biokin Pharmaceutical Co Ltd SHSE:688506
79 GF Score
Price ¥238.62
GF Value ¥287.73
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Sichuan Biokin Pharmaceutical Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Sichuan Biokin Pharmaceutical Co Valuation Rank Related Terms

SHSE:688506
79GF Score
Sichuan Biokin Pharmaceutical Co Ltd SHSE:688506
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sichuan Biokin Pharmaceutical Co (SHSE:688506) Overvalued in 2026?

Based on GuruFocus' analysis, Sichuan Biokin Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥238.62 is trading 17.1% below its estimated GF Value™ of ¥287.73. GuruFocus considers Sichuan Biokin Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:688506:

  • Valuation Rank:
  • GF Value™: ¥287.73 vs. price of ¥238.62 (17.1% below fair value)
  • GF Score™: 79/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688506 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sichuan Biokin Pharmaceutical Co Business Description

Address No. 161, Baili Road, No. 1, Building 1, Cross-strait Science and Technology Industrial Park, Wenjiang District, Sichuan Province, Chengdu, CHN, 611130
Sichuan Biokin Pharmaceutical Co Ltd is a chemical drug and biological drug-based company that integrates drug research and development, production and marketing.
79GF Score

Get the complete analysis for SHSE:688506

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥238.62
Price
¥287.73
GF Value